Literature DB >> 9217119

Rhinocerebral mucormycosis: evolution of the disease and treatment options.

K L Peterson1, M Wang, R F Canalis, E Abemayor.   

Abstract

Rhinocerebral mucormycosis is recognized as a potentially aggressive and commonly fatal fungal infection. The classic presentation is involvement of nasal mucosa with invasion of the paranasal sinuses and orbit. Mucormycosis is most commonly seen in association with diabetic ketoacidosis, but disease demographics have changed with the onset of AIDS and the advent of powerful immunosuppressive drugs. Treatment includes aggressive debridement, systemic antifungal therapy, and control of underlying comorbid factors. Although surgical intervention remains essential, advances in medical therapy have permitted a more limited surgical approach to minimize functional loss without compromising survival. We present the UCLA experience with rhinocerebral mucormycosis from 1955 to 1995, with emphasis on the evolution of disease presentation and alternative treatment options.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217119     DOI: 10.1097/00005537-199707000-00004

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  44 in total

1.  Gastrointestinal mucormycosis: an evolving disease.

Authors:  Brad Spellberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

2.  Acute invasive fungal rhinosinusitis: our experience with 19 patients.

Authors:  Ahmet Emre Süslü; Oğuz Oğretmenoğlu; Nilda Süslü; Omer TaşkIn Yücel; Tevfik Metin Onerci
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

Review 3.  The role of fungi in diseases of the nose and sinuses.

Authors:  Zachary M Soler; Rodney J Schlosser
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

4.  Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles.

Authors:  A M Sugar; X P Liu
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Mucormycosis of the jaw after dental extractions: two case reports.

Authors:  Abdulaziz A Bakathir
Journal:  Sultan Qaboos Univ Med J       Date:  2006-12

6.  Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.

Authors:  Shingo Yano; Jiro Minami; Kaichi Nishiwaki; Takaki Shimada; Nobuaki Dobashi; Yuichi Yahagi; Yutaka Takei; Shinobu Takahara; Yoji Ogasawara; Katsuki Sugiyama; Yuko Yamaguchi; Takeshi Saito; Kinuyo Kasama; Hiroki Yokoyama; Tomohito Machishima; Atsushi Katsube; Noriko Usui; Keisuke Aiba
Journal:  Int J Hematol       Date:  2011-03-02       Impact factor: 2.490

7.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

8.  Disseminated zygomycosis due to Rhizopus schipperae after heatstroke.

Authors:  G M Anstead; D A Sutton; E H Thompson; I Weitzman; R A Otto; S K Ahuja
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

9.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

10.  Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.

Authors:  Saroj Gupta; Rashmi Goyal; Navinchandra M Kaore
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.